Overcoming the funding challenge: The cost of randomized controlled trials in the next decade

Research output: Contribution to journalReview articlepeer-review

34 Scopus citations

Abstract

Randomized controlled trials (RCTs) represent the gold standard of evidence-based medicine. However, over the last several decades, the cost associated with conducting RCTs has increased dramatically. Several factors contribute to higher costs associated with clinical trials. This paper describes important barriers to conducting surgical RCTs, identifies funding sources available to finance RCTs, and suggests strategies to maintain cost-efficient study practices as we move into the next decade.

Original languageEnglish
Pages (from-to)101-106
Number of pages6
JournalJournal of Bone and Joint Surgery
Volume94
Issue numberSUPPL. 1
DOIs
StatePublished - Jul 18 2012

Fingerprint

Dive into the research topics of 'Overcoming the funding challenge: The cost of randomized controlled trials in the next decade'. Together they form a unique fingerprint.

Cite this